Haplotype construction of the FRDA gene and evaluation of its role in type ll diabetes

European Journal of Human Genetics

Volumn 13, Issue 7, 2005, Pages 849-855

  Holmkvist, Johan ^a   Almgren, Peter ^a   Parikh, Hemang ^a   Zucchelli, Marco ^b   Kere, Juha ^b,c,d   Groop, Leif ^a   Lindgren, Cecilia M ^b,c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Association study; FRDA; Linkage disequilibrium; Meta analysis; Type II diabetes

Indexed keywords

FRATAXIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DATA ANALYSIS; DIABETOGENESIS; DISEASE PREDISPOSITION; DOWNSTREAM PROCESSING; FEMALE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGENY; PUBLICATION; SINGLE NUCLEOTIDE POLYMORPHISM; TRINUCLEOTIDE REPEAT;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; FRIEDREICH ATAXIA; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE INTOLERANCE; HAPLOTYPES; HUMANS; IRON-BINDING PROTEINS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; TRINUCLEOTIDE REPEATS; VARIATION (GENETICS);

ATAXIA;

EID: 21744460536     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201413     Document Type: Article

References (35)

1. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab Med 1998; 15: 539-553.
2. Finocchiaro G, Baio G, Micossi P, Pozza G, di Donato S: Glucose metabolism alterations in Friedreich's ataxia. Neurology 1988; 38: 1292-1296.
3. Campuzano V, Montermini L, Molto MD et al: Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996; 271: 1423-1427.
4. Hanis CL, Boerwinkle E, Chakraborty R et al: A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996; 13: 161-166.
5. Lindgren CM, Mahtani MM, Widen E et al: Genomewide search for type 2 diabetes mellitus susceptibility loci in Finnish families: the Botnia study. Am J Hum Genet 2002; 70: 509-516.
6. Luo TH, Zhao Y, Li G et al: A genome-wide search for Type II diabetes susceptibility genes in Chinese Hans. Diabetologia 2001; 44: 501-506.
7. Pratley RE, Thompson DB, Prochazka M et al: An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest 1998; 101: 1757-1764.
8. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC: Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 1998; 47: 821-830.
9. Delatycki MB, Knight M, Koenig M, Cossee M, Williamson R, Forrest SM: G130V, a common FRDA point mutation, appears to have arisen from a common founder. Hum Genet 1999; 105: 343-346.
10. Campuzano V, Montermini L, Lutz Y et al: Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 1997; 6: 1771-1780.
11. Babcock M, de Silva D, Oaks R et al: Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 1997; 276: 1709-1712.
12. Mootha VK, Lindgren CM, Eriksson KF et al: PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-273.
13. Filla A, De Michele G, Cavalcanti F et al: The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet 1996; 59: 554-560.
14. t'Hart LM, Ruige JB, Dekker JM, Stehouwer CD, Maassen JA, Heine RJ: Altered beta-cell characteristics in impaired glucose tolerant carriers of a GAA trinucleotide repeat polymorphism in the frataxin gene. Diabetes 1999; 48: 924-926.
15. Dalgaard LT, Hansen T, Urhammer SA, Clausen JO, Eiberg H, Pedersen O: Intermediate expansions of a GAA repeat in the frataxin gene are not associated with type 2 diabetes or altered glucose-induced beta-cell function in Danish Caucasians. Diabetes 1999; 48: 914-917.
16. Dupont S, Dubois D, Vionnet N et al: No association between the Friedreich's ataxia gene and NIDDM in the French population. Diabetes 1998; 47: 1654-1656.
17. Lynn S, Hattersley AT, McCarthy MI, Frayling TM, Turnbull DM, Walker M: Intermediate expansions of a X25/frataxin gene GAA repeat and type II diabetes: assessment using parent-offspring trios. Diabetologia 2000; 43: 384-385.
18. Ristow M, Giannakidou E, Hebinck J et al: An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes 1998; 47: 851-854.
19. Shadrina MI, Miloserdova OV, Slominskii PA, Balabolkin MI, Limborskaiia SA: Association of polymorphic trinucleotide repeat (GAA)n of the Frataxin gene with diabetes mellitus type 2 in the Moscow population. Mol Boil (Mosk) 2002; 36: 37-39.
20. Groop L, Forsblom C, Lehtovirta M et al: Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 1996; 45: 1585-1593.
21. Tripathy D, Carlsson M, Almgren P et al: Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes 2000; 49: 975-980.
22. Edelstein SL, Knowler WC, Bain RP et al: Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997; 46: 701-710.
23. Shaw JE, Zimmet PZ, de Courten M et al: Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care 1999; 22: 399-402.
24. O'Connell JR, Weeks DE: PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-266.
25. Purcell S, Cherny SS, Sham PC: Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19: 149-150.
26. Gabriel SB, Schaffner SF, Nguyen H et al: The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
27. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
28. Kruglyak L, Daly MJ, Reeve Daly MP, Lander ES: Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58: 1347-1363.
29. Clayton D: A generalization of the transmission/disequilibrium test for. Am J Hum Genet 1999; 65: 1170-1177.
30. Zhao JH, Lissarrague S, Essioux L, Sham PC: GENECOUNTING: haplotype analysis with missing genotypes. Bioinformatics 2002; 18: 1694-1695.
31. Zhao JH: 2LD, GENECOUNTING and HAP: computer programs for linkage disequilibrium analysis. Bioinformatics 2004; 20: 1325-1326.
32. Altshuler D, Hirschhorn JN, Klannemark M et al: The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 76-80.
33. Gloyn AL, Weedon MN, Owen KR et al: Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 2003; 52: 568-572.
34. Jorde LB: Linkage Disequilibrium and the Search for Complex Disease Genes. Genome Res 2000; 10: 1435-1444.
35. Melton D, Brown J, Kenty G et al: Endocrine Pancreas Consortium, 2000, http://www.ncbi.nlm.nih.gov/, Accession number: BM022009.